Ju Fu Tang Biotech Holdings Co., Ltd. (listed on GEM, Hong Kong) filed its monthly return for the period ended 30 June 2026 on 6 July 2026. The filing shows no changes in either authorised or issued share capital during the month.

Authorised Share Capital • Authorised share capital remains at 500.00 million ordinary shares with a par value of HKD 0.16, equivalent to HKD 80.00 million.

Issued and Treasury Shares • Issued shares stayed at 301.86 million. • The company held zero treasury shares, and no repurchases or cancellations occurred in June.

Public Float • Management confirmed compliance with the minimum public-float requirement of 25% of total issued shares.

Share Option Position • No options were exercised in June. • Outstanding options under the 24 March 2016 scheme total 19.84 million: – 10.70 million options at an exercise price of HKD 0.315, expiring 11 July 2026. – 9.14 million options at an exercise price of HKD 0.163, expiring 17 March 2027. • No funds were raised from option exercises during the month.

Other Equity Instruments • The company reported no warrants, convertible securities, or other agreements that could lead to share issuance. • There were no other movements in share capital or treasury shares.

Compliance Statement • The board affirmed that all securities matters in June complied with Hong Kong listing rules and other applicable regulations.

With no equity movements and adequate public float confirmed, Ju Fu Tang Biotech maintains a stable capital structure heading into the second half of 2026.